Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing-Reference-Cited by-同舟云学术

Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing

Published:2013-08 Issue:2 Volume:81 Page:200-206
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

v. Laffert Maximilian,Warth Arne,Penzel Roland,Schirmacher Peter,Jonigk Danny,Kreipe Hans,Schildhaus Hans-Ulrich,Merkelbach-Bruse Sabine,Büttner Reinhard,Reu Simone,Kerler Rosi,Jung Andreas,Kirchner Thomas,Wölfel Cornelius,Petersen Iver,Rodriguez Regulo,Jochum Wolfram,Bartsch Holger,Fisseler-Eckhoff Annette,Berg Erika,Lenze Dido,Dietel Manfred,Hummel Michael

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2009

2. Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables;Berghmans;Ther Adv Med Oncol,2011

3. Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations;Berghmans;Eur Respir J,2011

4. Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities;Gaughan;Ther Adv Med Oncol,2011

5. The path to personalized medicine;Hamburg;N Engl J Med,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of potential reference measurement procedure and reference materials for EML4-ALK fusion variants measurement;2024-09-10

2. Молекулярні біомаркери в менеджменті пацієнтів з недрібноклітинним раком легень;Practical oncology;2024-08-02

3. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing;Virchows Archiv;2021-06-25

4. Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results;Cancers;2021-05-12

5. Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer;Lung Cancer;2021-01